Abstract
Severe inflammatory responses after major surgeries, trauma, and infection develop multiple organ dysfunction. In the mechanisms of the pathogenesis of these responses, activated neutrophils are thought to be important in terms of their ability to produce various kinds of proteinases, which can degrade various proteins constructing human tissues. Among their proteinases, neutrophil elastase is the strongest serine proteinase secreted from activated neutrophils. Thus, we examined in this study the inhibitory effect and therapeutic efficacy of newly produced recombinant human Kunitz-type proteinase inhibitor (R-020), which coded the second domain of human urinary trypsin inhibitor. R-020 was effective in significantly improving the survival rate after induction of the rat lethal peritonitis model (cecal ligation and punctureinduced septic shock model). We suggest that various serine proteinases are implicated in the pathogenesis of neutrophil-related multiple organ failure and that recombinant human Kunitz-type proteinase inhibitor might be effective in the treatment of these kinds of organ dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Evans, S. W. and J. T.Whicher. 1992. An overview of the inflammatory response.In Biochemistry of Inflammation. J. T. Whicher and S. W. Evans, editors. Kluwer Academic Publisher, 1–15.
Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, andW. J. Sibbald. 1992. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Chest 101:1644–1662.
Christmans, J. W. 1992. Potential treatment of sepsis syndrome with cytokine-specific agents.Chest 102:613–617.
Weiss, S. J. 1989. Tissue destruction by neutrophils.N. Engl. J. Med. 320:365–376.
Donnelly, S. C., andC. Haslett. 1992. Cellular mechanisms of acute lung injury: Implications for future treatment in the adult respiratory distress syndrome.Thorax 47:260–263.
Oka, Y., A. Murata, J. Nishijima, M. Ogawa, andT. Mori. 1993. The mechanism of hepatic cellular injury in sepsis: An in vitro study into the implications of cytokines and neutrophils in its pathogenesis.J. Surg. Res. 55:1–8.
Oka, Y., A. Murata, J. Nishijima, N. Hiraoka, T. Yasuda, K. Kitagawa, M. Ogawa, andT. Mori. 1991. Inhibitory effect of pentoxifylline and prostaglandin E1 on the release of neutrophil elastase from FMLP-stimulated neutrophils.J. Med. 22:371–382.
Grebhard, W., andHochstrasser, K. 1986. Inter-α-trypsin inhibitor and its close relatives.In Proteinase Inhibitors. A. J. Barret and G. Salvesen, editors. Elsevier Science, Amsterdam. 389–401.
Ohnishi, H., K. Suzuki, T. Niho, C. Ito, andK. Yamaguchi. 1985. Protective effects of urinary trypsin inhibitor in experimental shock.Jpn. J. Pharmacol. 39:137–144.
Kashimoto, S., M. Nakagomi, A. Nonaka, andT. Kumazawa. 1990. The effects of ulinastatin on cardiac and hepatic energy metabolism in rats subjected to hypovolemic shock.J. Anesth. 4:40–44.
Kudo, Y., T. Egashira, andY. Yamanaka. 1990. Protective effect of ulinastatin against liver injury caused by ischemia-reperfuion in rats.Jpn. J. Pharmacol. 60:239–245.
Cumming, A. D., andG. R. Nimmo. 1992. Hemodynamic, renal, and hormonal actions of aprotinin in an ovine model of septic shock.Crit. Care Med. 20:1134–1139.
Morishita, H., T. Yamakawa, T. Matsusue, T. Kusuyama, R. Sameshima-Aruga, J. Hirose, A. Nii, T. Miura, M. Isaji, R. Horisawa-Nakano, Y. Nagase, T. Kanamori, M. Nobuhara, R. Tanaka, S. Koyama, andM. Naotsuka. 1994. Novel factor Xa and plasma kallikrein inhibitory activities of the second Kunitz-type inhibitory domain of urinary trypsin inhibitor produced inEscherichia coli.Thromb Res. 73:193–204.
Lowry, O. H., N. J. Rosebrough, A. L. Farr, R. J. Randall. 1951. Protein measurement with the Folin phenol reagent.J. Biol. Chem. 193:265–275.
Wichterman, K. A., A. E. Baue, andL. H. Chaudry. 1980. Sepsis and septic shock: A review of laboratory models and a proposal.J. Surg. Res. 29:189–201.
Janoff, A. 1985. Elastase in tissue injury.Annu. Rev. Med. 36:207–216.
Schlag, G., andH. Redl. 1986. The proteinases in shock.Resuscitation 14:3–21.
Endo, S., K. Inada, K. Taki, S. Hoshi, andM. Yoshida. 1992. Inhibitory effects of ulinastatin on the production of cytokines: Implications for the prevention of septicemic shock.Clin. Ther. 12:323–326.
St. John, R.C. 1993. Immunologic therapy for ARDS, septic shock, and multiple organ failure.Chest 103:932–943.
Doherty, G. M., D. J. Venzon, M. J. Merino, et al. 1992. Recombinant interleukin-1 receptor antagonist (IL-1ra): Effective therapy against gram-negative sepsis in rats.Surgery 112:188–194.
Bone, R.C. 1992. Inhibitors of complement and neutrophils: A critical evaluation of their roles in the treatment of sepsis.Crit. Care Med. 20:891–898.
Pober, J. S., andR. S. Cotran. 1990. Cytokines and endothelial cell biology.Physiol. Rev. 70:427–451.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murata, A., Toda, H., Uda, K.I. et al. Protective effect of recombinant neutrophil elastase inhibitor (R-020) on sepsis-induced organ injury in rat. Inflammation 18, 337–347 (1994). https://doi.org/10.1007/BF01534432
Issue Date:
DOI: https://doi.org/10.1007/BF01534432